The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials

Clinical Infectious Diseases

Volumn 34, Issue 8, 2002, Pages 1115-1121

  Mannheimer, Sharon ^a,b   Friedland, Gerald ^c   Matts, John ^d   Child, Carroll ^e   Chesney, Margaret ^e  

^a HARLEM HOSPITAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CLINICAL TRIAL; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; RNA ANALYSIS; TREATMENT OUTCOME; VIREMIA;

ADULT; AGE FACTORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CLINICAL TRIALS; FEMALE; GUIDELINE ADHERENCE; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE; STATISTICS; TREATMENT OUTCOME;

EID: 0037090271     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/339074     Document Type: Article

References (42)

1. The era of adherence in antiretroviral therapy
2. Adherence and effectiveness of protease inhibitors in clinical practice
3. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. The INCAS trial
4. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
5. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
6. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens
7. Virologic success rates drop off sharply with decreasing levels of adherence to antiretroviral therapy
8. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
9. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy
10. Factors influencing survival in HIV infected patients treated with HAART
11. Non-adherence to triple combination therapy is predictive of AIDS progression and death in HIV-positive men and women
12. Adherence in patients treated with HAART: Influence in hospital admissions
13. Patient compliance and medical research: Issues in methodology
14. Detection methods and strategies for improving medication compliance
15. Measurement of medication compliance in a clinical setting
16. Patient and clinic factors predictive of missed visits and inactive status in a multicenter clinical trial
17. How often is medication taken as prescribed? A novel assessment technique
18. Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring
19. Relationship between demographic and clinical disease characteristics and medication adherence among patients in CHORUS
20. The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial
21. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral chelator
22. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial
23. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy
24. Perceptions, acceptance and adherence to antiretrovirals among prisoners
25. Prevalence and predictors of adherence to antiretroviral therapy (ART) among HIV+ women
26. Substance use predicts antiretroviral nonadherence in Harlem
27. Cofactors associated with participant compliance in two CPCRA trials
28. Racial differences in the use of drug therapy for HIV disease in an urban community
29. Zidovudine adherence among individuals with HIV infection
30. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy
31. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance
32. Patient characteristics and attitudes associated with antiretroviral adherence
33. Determinants of heterogeneous adherence to antiretroviral therapies (ART) in the multicenter AIDS cohort study (MACS)
34. The role of literacy, socio-economic status, and race in compliance to HIV medication regimens
35. The relationship between literacy, race, and adherence to potent anti-retroviral therapies
36. Black communities' belief in "AIDS as genocide": A barrier to overcome for HIV prevention
37. The use and the fear of antiretroviral therapy in HIV-infected individuals in Harlem
38. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments